Protalix BioTherapeutics Reports Fiscal Year 2022 Financial and Business Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected.
Treatments for blood cancer and rare diseases are the target markets, but investors are well aware of the challenges that await after approval is received.